References
- Todd WF, Armstrong DG, Liswood PJ. Evaluation and treatment of the infected foot in a community teaching hospital. J Am Podiatr Med Assoc 1996;86(9):421–6
- Sanders LJ. Diabetes mellitus: prevention of amputation. J Am Podiatr Med Assoc 1994;84(7):322–8
- Armstrong DG, Lavery LA, Harkless LB. Who is at risk for diabetic foot ulceration? Clin Podiatr Med Surg 1998; 15(1): 11–9
- Apelqvist J. Wound healing in diabetes: outcome and costs. Clin Podiatr Med Surg 1998; 15 (1): 21–39
- Day MR, Harkless LB. Factors associated with pedal ulceration in patients with diabetes mellitus. J Am Podiatr Med Assoc 1997; 87(8):365–9
- Boulton AJ. The pathogenesis of diabetic foot problems: an overview. Diabetic Med 1996; 13 Suppl 1: 12–6S
- Young MJ, Breddy JL, Veves A, et al. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. Diabetes Care 1994;17(6):557–62
- McNeely MJ, Boyko EJ, Ahroni JH, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. Diabetes Care 1995;18(2):216–9
- Sykes MT, Godsey JB. Vascular evaluation of the problem diabetic foot. Clin Podiatr Med Surg 1998;15(1):49–83
- Sage RA. The management of foot ulcers: advances in podiatric medicine and surgery. Vol 1. St Louis: Mosby-Year Book, 1995:139–53
- Lavery LA, Vela SA, Lavery DC, et al. Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations. Diabetes Care 1996;19(8):818–21
- American Diabetes Association. Foot care in patients with diabetes mellitus. Diabetes Care 1998;21 (Suppl 1):54–5S
- Gibbons GW, Habershaw GM. Diabetic foot infections: anatomy and surgery. Infect Disease Clin North Am 1995;9(1): 131–42
- Marcinko DE. Antibiotic-impregnated polymethyl methacry- late beads. In: Infections of the foot: diagnosis and management. 1st ed. St Louis: Mosby-Year Book, 1998:174–6
- Faglia E, Favales F, Aldeghi A, et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer: a randomized study. Diabetes Care 1996;19(12): 1338–42
- Frykberg RG. Diabetic foot ulcers: current concepts. J Foot Ankle Surg 1998;37(5):440–6
- Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor- BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: a phase III randomized placebo-controlled double-blind study. Diabetes Care 1998;21(15):822–9
- Frykberg RG. Team approach toward lower extremity amputation prevention in diabetes. J Am Podiatr Med Assoc 1997;87(7): 305–12
- Armstrong DG, Lavery LA, Stern S, et al. Is prophylactic diabetes foot surgery dangerous? J Foot Ankle Surg 1996;35(6):585–90